CellCyte Genetics to Present at 2008 San Francisco RedChip Small-Cap Investor Conference

Thursday, June 5, 2008 General News J E 4
BOTHELL, Wash., June 4 CellCyte GeneticsCorporation's (CellCyte) (OTC Bulletin Board: CCYG) President and CEO, Gary A.Reys, will present at the 2008 San Francisco RedChip Small-Cap InvestorConference on Thursday, June 5, at 10:35 AM Pacific Daylight Time at thePalace Hotel in San Francisco. In addition, CellCyte will have a booth at theconference at which they will have a prototype demonstration of the Company'scell expansion bioreactor.

The presentation will be Web cast live with slides and archived for replayafter the presentation at:

About CellCyte Genetics

CellCyte Genetics Corporation is a biotechnology company engaged in thediscovery, development and commercialization of stem cell enabling therapeuticproducts. CellCyte is developing products to allow more efficient delivery andincreased retention of adult stem cells to diseased organs, such as the heart.The goal of these therapies is to increase the number of stem cells deliveredto a damaged organ, thereby markedly increasing organ healing and functionalrestoration. The Company's lead product in development, CCG-TH30, is designedto send autologous bone marrow-derived (adult) stem cells to the heart ofpatients after a heart attack.CellCyte Genetics | 1725 220th Street SE | Bothell | Washington | 98021 | USA For further information see: Symbol: OTCBB - CCYG; Frankfurt/Berlin Symbol - LK6 WKN. No.: A0MLCV.

SOURCE CellCyte Genetics Corporation


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Edwards Lifesciences to Present at the Goldman Sac...
Thousands to Greet 2,500 Riders as AIDS/LifeCycle ...